Cellular Biomedicine Group Inc (CBMG) Gross Profit Margin starting from the third quarter 2020 to third quarter 2019, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Cellular Biomedicine Group Inc   (NASDAQ: CBMG)


Cellular Biomedicine Group Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBMG Gross Profit Margin (Sep 30 2020)
Q3 		(Jun 30 2020)
Q2 		(Mar 31 2020)
Q1 		(Dec 31 2019)
Q4 		(Sep 30 2019)
Q3
Y / Y Revenue Change -87.66 %
Seq. Revenue Change -74.07 %
Revenue In Millions $0.03
Gross Profit Margin 76.41 %
Gross Profit Margin Total Ranking # 640
Gross Profit In Millions $0.02
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Third Quarter 2020 Gross Profit Margin
Cellular Biomedicine Group Inc achieved Gross Profit of $0 millions compare to Gross Loss of $0.00 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -74.07 % Cellular Biomedicine Group Inc managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 0 compare to Gross Loss of $0.00 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 76.41 %, above company average.


Observing third quarter 2020 results within Biotechnology & Pharmaceuticals industry 16 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 640.
Learn about Gross Margin
CBMG's Gross Profit Margin third quarter 2020 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 136
Overall # 622

Gross Profit Margin Statistics
High Average Low
97.61 % 51.18 % 8.83 %
(Mar 31 2014)   (Sep 30 2016)


CBMG Gross Income Trends • More of CBMG's Profitabilty Ratios • CBMG Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CBMG's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CBMG's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CBMG's Competitors
Gross Profit Margin Profit Margin for Cellular Biomedicine Group Inc 's Suppliers
Gross Profit Margin Profit Margin for CBMG's Customers

You may also want to know
CBMG's Annual Growth Rates CBMG's Profitability Ratios CBMG's Asset Turnover Ratio CBMG's Dividend Growth
CBMG's Roe CBMG's Valuation Ratios CBMG's Financial Strength Ratios CBMG's Gross Profit Growth
CBMG's Roa CBMG's Inventory Turnover Ratio CBMG's Growth Rates CBMG's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2020, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2020 MRQ Gross ProfitSep 30 2020 MRQ Revenue
Neurocrine Biosciences Inc   98.96 %$ 255.800  Millions$ 258.500  Millions
Exelixis Inc   96.22 %$ 222.367  Millions$ 231.092  Millions
Sorrento Therapeutics Inc   95.33 %$ 11.204  Millions$ 11.753  Millions
Agenus Inc  93.86 %$ 13.921  Millions$ 14.832  Millions
Seagen Inc   92.63 %$ 983.435  Millions$ 1,061.731  Millions
Coherus Oncology inc   92.07 %$ 104.551  Millions$ 113.551  Millions
Halozyme Therapeutics Inc   91.48 %$ 59.748  Millions$ 65.316  Millions
Zeo Scientifix Inc   89.76 %$ 0.883  Millions$ 0.983  Millions
Clarus Therapeutics Holdings Inc.  88.44 %$ 1.967  Millions$ 2.224  Millions
Biogen Inc   86.70 %$ 2,927.000  Millions$ 3,376.100  Millions
Gilead Sciences Inc   82.65 %$ 5,436.000  Millions$ 6,577.000  Millions
Regenxbio Inc   82.45 %$ 81.548  Millions$ 98.912  Millions
Lineage Cell Therapeutics Inc   82.14 %$ 0.469  Millions$ 0.571  Millions
Creative Medical Technology Holdings Inc   77.14 %$ 0.059  Millions$ 0.077  Millions
Acorda Therapeutics Inc   77.08 %$ 40.920  Millions$ 53.090  Millions
Adaptive Biotechnologies Corporation  76.98 %$ 20.246  Millions$ 26.299  Millions
Cellular Biomedicine Group Inc   76.41 %$ 0.025  Millions$ 0.032  Millions
Amgen Inc   75.70 %$ 4,862.000  Millions$ 6,423.000  Millions
Biocryst Pharmaceuticals Inc   75.14 %$ 4.585  Millions$ 6.102  Millions
Protalix Biotherapeutics inc   73.42 %$ 7.922  Millions$ 10.790  Millions
Aerie Pharmaceuticals Inc   73.20 %$ 14.700  Millions$ 20.081  Millions
La Jolla Pharmaceutical Company  72.56 %$ 6.583  Millions$ 9.072  Millions
Vericel Corporation  69.66 %$ 22.471  Millions$ 32.258  Millions
Bio techne Corp  67.45 %$ 137.731  Millions$ 204.199  Millions
Orchard Therapeutics Plc  66.62 %$ 1.331  Millions$ 1.998  Millions
Xtant Medical Holdings Inc   65.98 %$ 9.248  Millions$ 14.016  Millions
Polarityte Inc   59.48 %$ 1.985  Millions$ 3.337  Millions
Repligen Corp  57.87 %$ 54.434  Millions$ 94.060  Millions
Nanostring Technologies Inc   56.16 %$ 17.883  Millions$ 31.845  Millions
Elutia Inc   47.06 %$ 5.541  Millions$ 11.774  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.